| Metric | Q3 2026 | Q3 2025 |
|---|---|---|
| Revenue | 1,540.0 | 1,495.0 |
| Gross profit | 231.0 | 233.0 |
| Profit before tax | 222.0 | 38.0 |
| Net income | 196.0 | 46.0 |
| EPS (diluted, $ a share) | $1.29 | $0.31 |
A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.
| Net income, year on year | +326.1% |
|---|---|
| Revenue, year on year | +3.0% |
| Gross margin | 15.0% |
10-Q filed with the SEC, NYSE: CC. Figures from the filing's XBRL data; summary written with AI assistance from the filing.
Chemours Co: key numbers
- Share price
- $12.18Close, Nov 17
- Market cap
- $1.83B
- Shares outstanding
- 150.53MLatest SEC cover page
- Sector
- Industrial Applications and Services
- Industry
- Chemicals & Allied ProductsSIC 2800
Today's reference numbers, updated daily. Not a valuation or a recommendation.
More from Chemours Co
All →Chemours Financial Results
Chemours reported third quarter 2026 net sales of $1.5 billion, driven by a 10% pricing increase in Titanium Technologies and 26% growth in APM Performance Solutions. The company achieved net income of $196 million, significantly up from $46 million in the prior-year quarter, while also completing the sale of its Kuan Yin property for approximately $340 million.
“Our third-quarter results demonstrate strong year-over-year performance in TT and APM, reflecting pricing execution in TiO2 and increased demand across Performance Solutions’ high-value AI infrastructure including data center and semiconductor end markets.”
Denise Dignam, Chemours President and CEO
“We also continued to make meaningful progress under our Pathway to Thrive, including reaching a settlement with the State of North Carolina, driving operational improvements through the Chemours Business System, and closing the sale of the final parcel of land associated with our former Kuan Yin property.”
Denise Dignam, Chemours President and CEO